2025-04-01 12:34:07
Latest Post
KEC International wins New Orders of Rs. 1,236 crores
Newgen Software Technologies Ltd receives order worth Rs. 17.51 crore
Salila Pande Takes Charge as the MD & CEO of SBI Card
Mishra Dhatu Nigam Ltd - Performance Highlights FY 2024- 25
Bright Completes Two Bright Years on BSE: A Journey of Excellence, Innovation & Digital Transformation
Stock Report
Ind-Swift Laboratories Ltd reports consolidated PAT of Rs. 24.47 crore in Q2FY22
Posted On : 2021-11-05 17:48:31( TIMEZONE : IST )
Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 242.7898 crores during the period ended September 30, 2021 as compared to Rs. 255.7522 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 24.4705 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 18.8041 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 4.14 for the period ended September 30, 2021 as compared to Rs. 3.18 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 242.7898 crs | ₹255.7522 crs |  -5.07% |
| Net Profit | ₹24.4705 crs | ₹18.8041 crs |  30.13% |
| EPS | ₹4.14 | ₹3.18 | 30.19% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 242.7898 crores during the period ended September 30, 2021 as compared to Rs.233.6323 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.24.4705 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.9.9220 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.4.14 for the period ended September 30, 2021 as compared to Rs.1.58 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 242.7898 crs | ₹233.6323 crs | 3.92% |
| Net Profit | ₹24.4705 crs | ₹9.9220 crs | 146.63% |
| EPS | ₹4.14 | ₹1.58 | 162.03% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.498.5420 crores during the 6 Months period ended September 30, 2021 as compared to Rs.449.8294 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.43.2747 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.14.4942 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.7.32 for the 6 Months period ended September 30, 2021 as compared to Rs.2.45 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹498.5420 crs | ₹449.8294 crs | 10.83% |
| Net Profit | ₹43.2747 crs | ₹14.4942 crs | 198.57% |
| EPS | ₹7.32 | ₹2.45 | 198.78% |
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 77.20 as compared to the previous close of Rs. 74.10. The total number of shares traded during the day was 78785 in over 952 trades.
The stock hit an intraday high of Rs. 79.00 and intraday low of 76.10. The net turnover during the day was Rs. 6100171.00.
